EN DE

Tarkim Bitki Koruma Sanayi ve Ticaret A.S. (TARKM) Fair Value & Analysis

Basic Materials · TR · Market cap 9.7B TRY

TB Tarkim Bitki Koruma Sanayi ve Ticaret A.S. TARKM · IS
Price463.00 TRY
Fair Value201.98 TRY
Upside-56.4%
Quality44/100
Expensive Growth
Thin margins · 0.7% net margin
Low debt · negative free cash flow
Trails peers (3/12)
Moderate moat 45/100
Watch Tarkim Bitki Koruma Sanayi ve Ticaret A.S. for free, get notified when fair value or trend changes. Watch for free
Evidence: Low Range 141.54 TRY – 262.41 TRY Share as image

Fair value as of: Aug 1, 2026

From 6 valuation models · updated today

Share price −9.6% over the past month.

What matters now

  • The price sits above even our optimistic bull case (262.41 TRY). The favourable scenario is already priced in.
  • Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • A fairly wide model range (141.54 TRY to 262.41 TRY) leaves room in how you read the outcome.

Price vs Fair Value (12 months)

593.50 TRY 323.50 TRY Fair Value 201.98 TRY Aug 2025 Jul 2026

12‑month range 323.50 TRY – 593.50 TRY · fair‑value band 141.54 TRY – 262.41 TRY · the 463.00 TRY price screens above the 201.98 TRY fair value. As of Aug 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Tarkim Bitki Koruma Sanayi ve Ticaret A.S. (TARKM) currently trades at 463.00 TRY, while our model-based Fair Value estimate is 201.98 TRY, implying the stock looks roughly 56.4% overvalued today. We read business quality at 44/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Tarkim Bitki Koruma Sanayi ve Ticaret A.S. generated revenue of 2.1B TRY at a net margin of 0.7%. Revenue grew 2.5% year over year. It earns a return on equity of 0.5%. Net debt stands at 835M TRY. Fundamentals as of Aug 1, 2026

Our scenario range runs from 141.54 TRY (bear case) to 262.41 TRY (bull case); at 463.00 TRY, the current price sits above that range. The share trades about 26% below its 52-week high and 44% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -18% fair-value upside, at -56%, TARKM screens richer than that median.

Key figures & financial health

Revenue (TTM) 2.1B TRY
Revenue growth (YoY) +2.5%
Net margin 0.7%
Return on equity 0.5%
Free cash flow −586M TRY FY2025
P/E ratio 712.3
More key figures
Operating margin 28.8%
EPS (TTM) 0.6500 TRY
EPS growth (YoY) +232%
Net debt 835M TRY FY2025

Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 44/100
Profitability 15
Quality Growth 45
Cashflow 20
Fin. Strength 61
Investment 0
Low Volatility 67
Momentum 54
52W Momentum 54
Net Issuance 82

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Tarkim Bitki Koruma Sanayi ve Ticaret A.S. produces, sells, and markets plant protection products. The company offers fungicide, herbicide, and insecticides. It is also involved in various plant programs. The company was incorporated in 2009 and is based in Manisa, Turkey.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Tarkim Bitki Koruma Sanayi ve Ticaret A.S. reported revenue of 2.0B TRY in FY2025 versus 252M TRY in FY2021, a compound +68.7%/yr. Reported net income was −97.1M TRY in FY2025.

Revenue +68.7%/yr
FY21 252M TRY
FY22 1.4B TRY
FY23 1.4B TRY
FY24 1.8B TRY
FY25 2.0B TRY
Net income
FY21 27.1M TRY
FY22 421M TRY
FY23 −250M TRY
FY24 133M TRY
FY25 −97.1M TRY

Is TARKM fairly valued? → Check now

Share or link this analysis
📋 Free embed code + live data for your site

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Tarkim Bitki Koruma Sanayi ve Ticaret A.S. Fair Value". https://www.fairvalue-calculator.com/stock/TARKM

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 / 22
FUTURE 13 / 35
PAST 2 / 24
HEALTH 99 / 97
DIVIDEND 0 / 33

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $77.46 $39.29 -49%
Nutrien Ltd NTR C$93.63 C$77.05 -18%
Qinghai Salt Lake Industry Co 000792 ¥29.45 ¥21.15 -28%
CF Industries Holdings C1FI34 R$533.71 R$176.57 -67%
SABIC Agri-Nutrients Company 2020 122.90 SAR 127.31 SAR +4%
Yara International ASA YRAIF $47.55 $68.66 +44%
Yunnan Yuntianhua Co 600096 ¥32.53 ¥50.49 +55%
The Mosaic Company MOSC34 R$19.06 R$12.25 -36%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥44.31 ¥38.01 -14%
Coromandel International Limited COROMANDEL ₹1,797 ₹1,414 -21%

Compare Tarkim Bitki Koruma Sanayi ve Ticaret A.S. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Tarkim Bitki Koruma Sanayi ve Ticaret A.S. (TARKM) overvalued or undervalued?
As of Aug 1, 2026, our model estimates a fair value of 201.98 TRY versus a price of 463.00 TRY, about −56% (overvalued).
What is the fair value of TARKM?
Our model-based fair value for Tarkim Bitki Koruma Sanayi ve Ticaret A.S. is 201.98 TRY (as of Aug 1, 2026), built from audited fundamentals. The current price is 463.00 TRY.
What is the quality score of TARKM?
Tarkim Bitki Koruma Sanayi ve Ticaret A.S. has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Tarkim Bitki Koruma Sanayi ve Ticaret A.S. (TARKM)?
Tarkim Bitki Koruma Sanayi ve Ticaret A.S. reported trailing-twelve-month revenue of about 2.1B TRY (latest available figure, as of Aug 1, 2026).
What is the net profit margin of TARKM?
The net profit margin of Tarkim Bitki Koruma Sanayi ve Ticaret A.S. is about 0.7%, meaning it keeps roughly 0.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Tarkim Bitki Koruma Sanayi ve Ticaret A.S. and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.